X4 Pharmaceuticals (XFOR) Total Debt Growth (1y) (2018 - 2025)
X4 Pharmaceuticals (XFOR) Total Debt Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,192.35 Bn | 67,192.06 Bn | - | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | 103.99% |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.52 Bn | 466.73 Bn | 1.35 Bn | 3.84% |
| 5 | Vertex Pharmaceuticals | 121.73 Bn | 114.48 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.88 Bn | 61.13 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 63.11 Bn | 63.11 Bn | - | - |
| 8 | Argenx Se | 55.88 Bn | 50.70 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | - |
| 10 | X4 Pharmaceuticals | 167.50 Mn | -49.55 Mn | 2.20 Mn | -0.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.56% |
| Sep 30, 2025 | 1.11% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 37.95% |
| Dec 31, 2024 | 38.22% |
| Sep 30, 2024 | 38.48% |
| Jun 30, 2024 | 130.06% |
| Mar 31, 2024 | 69.31% |
| Dec 31, 2023 | 61.38% |
| Sep 30, 2023 | 15.28% |
| Jun 30, 2023 | -20.69% |
| Mar 31, 2023 | -2.54% |
| Dec 31, 2022 | 1.56% |
| Sep 30, 2022 | 39.68% |
| Jun 30, 2022 | 26.48% |
| Mar 31, 2022 | -0.40% |
| Dec 31, 2021 | 0.35% |
| Sep 30, 2021 | 32.11% |
| Jun 30, 2021 | 30.00% |
| Mar 31, 2021 | 33.42% |